Mount Sinai Study Identifies Reversible Damage from Alzheimer's Gene APOE4

Researchers at Mount Sinai have detailed how the Alzheimer's risk gene APOE4 damages brain blood vessels and contributes to harmful protein accumulation. Crucially, experiments demonstrated that some of these effects could be reversed, identifying promising new targets for treating Alzheimer's and other neurodegenerative diseases. This discovery offers a potential pathway for future therapeutic interventions.